Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Clinical Feasibility of Birth- Track II System (BT)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2009 by Barnev Ltd.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Barnev Ltd
ClinicalTrials.gov Identifier:
NCT00840710
First received: February 8, 2009
Last updated: December 27, 2009
Last verified: February 2009

February 8, 2009
December 27, 2009
February 2010
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00840710 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Clinical Feasibility of Birth- Track II System
Clinical Feasibility of Birth- Track II System

The Study purpose is to monitor the cervix dilation, head descent, FHR and to follow contraction in a women in active labor.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample

Women in active labor

  • Obstetrics
  • Labor
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
15
August 2010
Not Provided

Inclusion Criteria:

  1. Laboring women referred to the Maternity Center in active labor (3cm dilatation and contractions).
  2. Gestational age 37-42 weeks. (GA)
  3. Single fetus
  4. Subjects who understood, agreed and signed the informed consent form

Exclusion Criteria:

  1. Women with abnormal placentation (placenta previa)
  2. Abnormal fetal presentation (breech presentation)
  3. Maternal History of HIV and/or blood transmitted hepatitis and/or active genital Herpes.
  4. Need for immediate delivery (cord prolapsed or suspected placental abruption)
Female
17 Years to 50 Years
Yes
Contact: Jacob Bornestein, Phd. 049107207
Israel
 
NCT00840710
BT-II-IS-001
No
Clinical Trial Manager, Barnev Ltd
Barnev Ltd
Not Provided
Principal Investigator: Jacob Bornstein, PhD Westren Gallilie Hospital
Barnev Ltd
February 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP